Genomics

Dataset Information

0

HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer

ABSTRACT: HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer

PROVIDER: PRJNA691899 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR13428300.fastq.gz Fastqsanger.gz
SRR13428301.fastq.gz Fastqsanger.gz
SRR13428302.fastq.gz Fastqsanger.gz
SRR13428303.fastq.gz Fastqsanger.gz
SRR13428304.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 143

Similar Datasets

Transcriptomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq HDAC3 KO p65 KO]
2023-07-14 | GSE164756 | GEO
Transcriptomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq HDAC3 KO NKX2-1 KO]
2023-07-14 | GSE164755 | GEO
Transcriptomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq GEMM tumors]
2023-07-14 | GSE164758 | GEO
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [ChIP-seq GEMM tumors]
2023-07-14 | GSE164754 | GEO
Transcriptomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq trametinib entinostat treatment]
2023-07-14 | GSE164757 | GEO
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [ChIP-seq KL LJE1 cells]
2023-07-14 | GSE164753 | GEO
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq HDAC3 KO p65 KO]
| PRJNA691907 | ENA
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq HDAC3 KO NKX2-1 KO]
| PRJNA691908 | ENA
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [ChIP-seq GEMM tumors]
| PRJNA691905 | ENA
Genomics HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer [RNA-seq GEMM tumors]
| PRJNA691904 | ENA